Predictors of Clinically Important Improvements in Motor Function and Daily Use of Affected Arm after a Botulinum Toxin A Injection in Patients with Chronic Stroke

Identifying patients who can gain minimal clinically important difference (MCID) in active motor function in the affected upper extremity (UE) after a botulinum toxin A (BoNT-A) injection for post-stroke spasticity is important. Eighty-eight participants received a BoNT-A injection in the affected U...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Jen-Wen, Wu, Wen-Chi, Chen, Yi-Ju, Pong, Ya-Ping, Chang, Ku-Chou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778339/
https://www.ncbi.nlm.nih.gov/pubmed/35050990
http://dx.doi.org/10.3390/toxins14010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778339/
https://www.ncbi.nlm.nih.gov/pubmed/35050990
http://dx.doi.org/10.3390/toxins14010013

Ejemplares similares